Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma

Neuroscience Letters

Volumn 531, Issue 2, 2012, Pages 204-208

  Chang, Chongwang ^a   Shi, Hangyu ^b   Wang, Chao ^a   Wang, Jing ^a   Geng, Ning ^a   Jiang, Xue ^a   Wang, Xuelian ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XI AN CHILDREN S HOSPITAL   (China)

Author keywords

Glioma; MicroRNA 375; Prognosis; Real time quantitative RT PCR

Indexed keywords

MICRORNA 375;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; DOWN-REGULATION; FEMALE; GLIOMA; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84870402500     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.10.021     Document Type: Article

References (27)

1. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
2. Avnit-Sagi T., Vana T., Walker M.D. Transcriptional mechanisms controlling miR-375 gene expression in the pancreas. Experiment and Diabetes Research 2012, 2012:891216.
3. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nature Reviews Cancer 2006, 6:857-866.
4. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2999-3004.
5. Chang Y., Yan W., He X., Zhang L., Li C., Huang H., Nace G., Geller D.A., Lin J., Tsung A. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology 2012, 143:177-187.
6. Cho W.C. OncomiRs: the discovery and progress of microRNAs in cancers. Molecular Cancer 2007, 6:60.
7. Ding L., Xu Y., Zhang W., Deng Y., Si M., Du Y., Yao H., Liu X., Ke Y., Si J., Zhou T. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Research 2010, 20:784-793.
8. Dunbar E., Yachnis A.T. Glioma diagnosis: immunohistochemistry and beyond. Advances in Anatomic Pathology 2010, 17:187-201.
9. Gaur A., Jewell D.A., Liang Y., Ridzon D., Moore J.H., Chen C., Ambros V.R., Israel M.A. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Research 2007, 67:2456-2468.
10. Giricz O., Reynolds P.A., Ramnauth A., Liu C., Wang T., Stead L., Childs G., Rohan T., Shapiro N., Fineberg S., Kenny P.A., Loudig O. Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity. Journal of Pathology 2012, 226:108-119.
11. C.M. Hsu, P.M. Lin, Y.M. Wang, Z.J. Chen, S.F. Lin, M.Y. Yang, Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biology, in press.
12. Kinoshita T., Hanazawa T., Nohata N., Okamoto Y., Seki N. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways. Journal of Human Genetics 2012, 57:556-563.
13. Liu A.M., Poon R.T., Luk J.M. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochemical and Biophysical Research Communications 2010, 394:623-627.
14. Ma R., Yan W., Zhang G., Lv H., Liu Z., Fang F., Zhang W., Zhang J., Tao T., You Y., Jiang T., Kang X. Upregulation of miR-196b confers a poor prognosis in glioblastoma patients via inducing a proliferative phenotype. PLoS ONE 2012, 7:e38096.
15. Nishikawa E., Osada H., Okazaki Y., Arima C., Tomida S., Tatematsu Y., Taguchi A., Shimada Y., Yanagisawa K., Yatabe Y., Toyokuni S., Sekido Y., Takahashi T. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Research 2011, 71:6165-6173.
16. Ohgaki H., Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathologica 2005, 109:93-108.
17. Smits A., Jin Z., Elsir T., Pedder H., Nistér M., Alafuzoff I., Dimberg A., Edqvist P.H., Pontén F., Aronica E., Birnir B. GABA-A channel subunit expression in human glioma correlates with tumor histology and clinical outcome. PLoS ONE 2010, 7:e37041.
18. Sotiropoulou G., Pampalakis G., Lianidou E., Mourelatos Z. Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA 2009, 15:1443-1461.
19. Szczyrba J., Nolte E., Wach S., Kremmer E., Stöhr R., Hartmann A., Wieland W., Wullich B., Grässer F.A. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Molecular Cancer Research 2011, 9:791-800.
20. Tsukamoto Y., Nakada C., Noguchi T., Tanigawa M., Nguyen L.T., Uchida T., Hijiya N., Matsuura K., Fujioka T., Seto M., Moriyama M. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Research 2010, 70:2339-2349.
21. Wang D., Qiu C., Zhang H., Wang J., Cui Q., Yin Y. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS ONE 2010, 5:e13067.
22. Wang F., Li Y., Zhou J., Xu J., Peng C., Ye F., Shen Y., Lu W., Wan X., Xie X. miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. American Journal of Pathology 2011, 179:2580-2588.
23. Xu Y., Deng Y., Yan X., Zhou T. Targeting miR-375 in gastric cancer. Expert Opinion on Therapeutic Targets 2011, 15:961-972.
24. Yabushita S., Fukamachi K., Tanaka H., Sumida K., Deguchi Y., Sukata T., Kawamura S., Uwagawa S., Suzui M., Tsuda H. Circulating MicroRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas. Pancreas 2012, 41:1013-1018.
25. Zeng Y. Principles of micro-RNA production and maturation. Oncogene 2006, 25:6156-6162.
26. Zhang H., Mishra A., Chintagari N.R., Gou D., Liu L. Micro-RNA-375 inhibits lung surfactant secretion by altering cytoskeleton reorganization. IUBMB Life 2010, 62:78-83.
27. Zhang X., Yan Z., Zhang J., Gong L., Li W., Cui J., Liu Y., Gao Z., Li J., Shen L., Lu Y. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Annals of Oncology 2011, 22:2257-2266.